ViroGates A/S (VIRO.CO)

DKK 7.0

(1.74%)

Operating Income Summary of ViroGates A/S

ViroGates A/S's latest annual operating income in 2023 was -12.56 Million DKK , down -15.86% from previous year.
ViroGates A/S's latest quarterly operating income in 2024 Q2 was -4.21 Million DKK , down -13.61% from previous quarter.
ViroGates A/S reported an annual operating income of -10.84 Million DKK in 2022, up 42.28% from previous year.
ViroGates A/S reported an annual operating income of -18.78 Million DKK in 2021, up 4.76% from previous year.
ViroGates A/S reported a quarterly operating income of -3.71 Million DKK for 2024 Q1, down -16.37% from previous quarter.
ViroGates A/S reported a quarterly operating income of -12.56 Million DKK for 2023 FY, down -15.86% from previous quarter.

Annual Operating Income Chart of ViroGates A/S (2023 - 2015)

Historical Annual Operating Income of ViroGates A/S (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-12.56 Million DKK	-15.86%
2022	-10.84 Million DKK	42.28%
2021	-18.78 Million DKK	4.76%
2020	-19.72 Million DKK	-0.03%
2019	-19.72 Million DKK	-8.95%
2018	-18.1 Million DKK	-135.34%
2017	-7.69 Million DKK	-10.88%
2016	-6.93 Million DKK	-29.52%
2015	-5.35 Million DKK	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-4.21 Million DKK	-13.61%
2024 Q1	-3.71 Million DKK	-16.37%
2023 FY	-12.56 Million DKK	-15.86%
2023 Q3	-2.21 Million DKK	42.89%
2023 Q1	-3.27 Million DKK	-74.32%
2023 Q2	-3.88 Million DKK	-18.39%
2023 Q4	-3.18 Million DKK	-43.8%
2022 Q1	-3.43 Million DKK	20.77%
2022 FY	-10.84 Million DKK	42.28%
2022 Q4	-1.88 Million DKK	43.95%
2022 Q3	-3.35 Million DKK	-54.44%
2022 Q2	-2.17 Million DKK	36.72%
2021 Q2	-5.29 Million DKK	-15.13%
2021 Q1	-4.6 Million DKK	3.26%
2021 FY	-18.78 Million DKK	4.76%
2021 Q4	-4.33 Million DKK	4.94%
2021 Q3	-4.55 Million DKK	13.92%
2020 Q3	-3.97 Million DKK	12.78%
2020 Q1	-6.43 Million DKK	8.48%
2020 Q4	-4.75 Million DKK	-19.5%
2020 Q2	-4.56 Million DKK	29.08%
2020 FY	-19.72 Million DKK	-0.03%
2019 Q2	-4.59 Million DKK	-18.89%
2019 FY	-19.72 Million DKK	-8.95%
2019 Q4	-7.02 Million DKK	-65.9%
2019 Q3	-4.23 Million DKK	7.77%
2019 Q1	-3.86 Million DKK	53.82%
2018 Q4	-8.36 Million DKK	-199.66%
2018 Q3	-2.79 Million DKK	-389.57%
2018 Q1	-2.74 Million DKK	-47.38%
2018 Q2	964.18 Thousand DKK	135.1%
2018 FY	-18.1 Million DKK	-135.34%
2017 Q1	-1.3 Million DKK	0.0%
2017 Q3	-1.87 Million DKK	29.1%
2017 Q2	-2.64 Million DKK	-103.8%
2017 FY	-7.69 Million DKK	-10.88%
2017 Q4	-1.86 Million DKK	0.78%
2016 FY	-6.93 Million DKK	-29.52%
2015 FY	-5.35 Million DKK	0.0%

Peer Operating Income Comparison of ViroGates A/S

Name	Operating Income	Operating Income Difference
Ambu A/S	645 Million DKK	101.948%
ChemoMetec A/S	178.78 Million DKK	107.028%
Demant A/S	4.14 Billion DKK	100.303%
GN Store Nord A/S	869 Million DKK	101.446%
Scandinavian Medical Solutions A/S	16.62 Million DKK	175.571%